Tengjun Biotechnology Corp.
TJBHOTCConsumer Defensive
$2.00
+$0.00(+0.00%)
Market Cap$201422000
P/E Ratio—
52W High$2
52W Low$2
Tengjun Biotechnology Corp. (TJBH) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
TJBH · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2023Report Date: Aug 14, 2023EPS Actual
-$0.00
Revenue
—
Fiscal Period
Q3 FY2023
FY ends December
Report Date
Aug 14, 2023
After Market Close
TJBH reports quarterly as a OTC-listed Packaged Foods company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q4 FY2024 | Oct 24, 2024 | — | — | — | — | — | — |
| ◌ Q3 FY2024 | Sep 27, 2024 | — | — | — | — | — | — |
| ◌ Q3 FY2024 | Aug 29, 2024 | — | — | — | — | — | — |
| — Q3 FY2023 | Aug 14, 2023 | — | -$0.00 | — | — | — | — |
| — Q2 FY2023 | May 15, 2023 | — | $0.00 | — | $0.01B | — | — |
| — Q2 FY2023 | Apr 17, 2023 | — | $0.04 | — | $0.06B | — | — |
| — Q4 FY2022 | Nov 14, 2022 | — | $0.04 | — | $0.04B | — | — |
| — Q3 FY2022 | Aug 15, 2022 | — | -$0.05 | — | $0.05B | — | — |
Q4 FY2024
Oct 24, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Sep 27, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Aug 29, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2023
Aug 14, 2023
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2023
May 15, 2023
EPS Actual
$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q2 FY2023
Apr 17, 2023
EPS Actual
$0.04
EPS Est.
—
EPS Surpr.
—
Revenue
$0.06B
Q4 FY2022
Nov 14, 2022
EPS Actual
$0.04
EPS Est.
—
EPS Surpr.
—
Revenue
$0.04B
Q3 FY2022
Aug 15, 2022
EPS Actual
-$0.05
EPS Est.
—
EPS Surpr.
—
Revenue
$0.05B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $1.54 | $1.54 | $1.54 | 1 |
| Q2 FY2024 | $1.34 | $1.34 | $1.34 | 1 |
| Q1 FY2024 | $1.58 | $1.58 | $1.58 | 1 |
| Q4 FY2023 | $2.09 | $2.09 | $2.09 | 1 |
| Q3 FY2023 | $1.39 | $1.39 | $1.39 | 1 |
| Q2 FY2023 | $1.19 | $1.19 | $1.19 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q3 FY2023 | Aug 14, 2023 | — | $32.35 | $30.54 | -5.60% |
| — Q2 FY2023 | May 15, 2023 | — | $31.89 | $30.36 | -4.80% |
| — Q2 FY2023 | Apr 17, 2023 | — | $36.06 | $36.65 | +1.64% |
| — Q4 FY2022 | Nov 14, 2022 | — | $4.00 | $4.50 | +12.50% |
| — Q3 FY2022 | Aug 15, 2022 | — | No price data | $4.00 | — |
| — Q2 FY2022 | May 13, 2022 | — | No price data | $4.00 | — |
| — Q1 FY2022 | Mar 31, 2022 | — | No price data | $4.00 | — |
| — Q4 FY2021 | Oct 20, 2021 | — | No price data | $4.00 | — |
Q3 FY2023-5.60%
Report Date
Aug 14, 2023
EPS Beat/Miss
—
Price Before
$32.35
Price After
$30.54
Q2 FY2023-4.80%
Report Date
May 15, 2023
EPS Beat/Miss
—
Price Before
$31.89
Price After
$30.36
Q2 FY2023+1.64%
Report Date
Apr 17, 2023
EPS Beat/Miss
—
Price Before
$36.06
Price After
$36.65
Q4 FY2022+12.50%
Report Date
Nov 14, 2022
EPS Beat/Miss
—
Price Before
$4.00
Price After
$4.50
Q3 FY2022—
Report Date
Aug 15, 2022
EPS Beat/Miss
—
Price Before
—
Price After
$4.00
Q2 FY2022—
Report Date
May 13, 2022
EPS Beat/Miss
—
Price Before
—
Price After
$4.00
Q1 FY2022—
Report Date
Mar 31, 2022
EPS Beat/Miss
—
Price Before
—
Price After
$4.00
Q4 FY2021—
Report Date
Oct 20, 2021
EPS Beat/Miss
—
Price Before
—
Price After
$4.00
Beat Rate0 / 8 quarters
Largest Move+12.50% (Q4 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: TJBH ends December
Tengjun Biotechnology Corp. (TJBH) most recently reported earnings on August 14, 2023 for Q3 FY2023, posting EPS of $-0.00 (in line with the analyst consensus of —). The next TJBH earnings date is expected around September 1, 2026.
Each quarter, investors track TJBH earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. TJBH revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
TJBH's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
TJBH earnings · 4 questionsTengjun Biotechnology Corp.'s next earnings report is expected around September 1, 2026. TJBH typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; TJBH historically reports after market close (AMC).
TJBH earnings datewhen is TJBH earningsTJBH next earnings datewhen does TJBH report earningsTJBH earnings calendar
▸ Source: FMP · Tengjun Biotechnology Corp. SEC filings · US GAAP · Tengjun Biotechnology Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026